Daniel Kavanagh of Massachusetts General Hospital in the U.S. proposes to use a novel class of molecular probes to identify and characterize individual cells latently infected with HIV. If successful, this project will identify new markers that may be used to target and eliminate HIV-infected cells.
Grant ID
OPP1035888
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False